CVS Health
- Market cap
- 113.62B
- P/E (TTM)i
- 23.44
- P/Bi
- 1.43
- EPSi
- 1.39
- Div yieldi
- 2.99%
- 52W posi
- 49%
Anonymous reader poll. Unscientific, not investment advice.
Shares of CVS Health closed at 88.84, down 1.58%. The company carries a market value of roughly 113.62B, the #129 most valuable US-listed company we track. Trading at a P/E of 24.20, the stock is 25% below its own five-year norm of 32.17. It pays a dividend yielding 2.99% on a trailing basis. Wall Street's 18-analyst consensus lands on Buy, with a price target averaging 115.00 (+29% from here). Over the past year the stock has ranged from 68.48 to 110.00; it now sits 49% up that band.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 1 month.
- Recent price momentum is +7.0% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 299 U.S. stocks StockVane covers.
Valuation B+
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 23.4x | Better than 49% |
| Forward P/E | 13.6x | Better than 76% |
| Price / Sales | 0.3x | Better than 99% |
| P/E vs own 5-yr range | 69th pctl | Better than 41% |
Growth D+
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 7.6% | Better than 52% |
| Net income CAGR (3Y) | -25.7% | Better than 8% |
| Free cash flow CAGR (3Y) | -16.6% | Better than 18% |
Profitability F
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 13.8% | Better than 5% |
| Operating margin | 2.6% | Better than 5% |
| Net margin | 0.4% | Better than 4% |
| Return on equity | 2.3% | Better than 5% |
| Return on invested capital | 2.7% | Better than 8% |
Momentum C+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -9.1% | Better than 17% |
| 6-month return | 26.2% | Better than 74% |
| 12-month return (ex latest month) | 28.1% | Better than 53% |
| Distance below 52-week high | 19.2% | Better than 30% |
Financial Health C
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 0.8x | Better than 17% |
| Debt to assets | 106.3% | Better than 31% |
| Interest coverage | 1.7x | Better than 6% |
| Free cash flow / net income | 441.6% | Better than 95% |
Analyst View A
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 100.0% | Better than 92% |
| Upside to average target | 29.4% | Better than 79% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 90.27
- Open
- 90.09
- Day range
- 88.15 - 90.48
- Avg price
- 88.83
- Volume
- 21.88M
- Turnover
- 1.94B
- Turnover ratei
- 1.71%
- Volume ratioi
- 3.84
- Amplitudei
- 2.58%
- 52-week rangei
- 68.48 - 110.00
Valuation
- P/Ei
- 63.91
- P/E (TTM)i
- 23.44
- P/Bi
- 1.43
- EPSi
- 1.39
- Book value / shi
- 62.32
- Net profit
- 1.78B
- Net assets
- 79.70B
Share structure
- Market cap
- 113.62B
- Float capi
- 113.40B
- Shares out
- 1.28B
- Float sharesi
- 1.28B
Dividend & listing
- Div yield (TTM)i
- 2.99%
- Dividend (TTM)
- 2.66
- Listing date
- 1970-01-01
19.2% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-213.88M net over the window
Short interest
- Shares short
- 18.11M
- % of floati
- 1.42%
- Days to coveri
- 2.81
- As of
- 2026-08-31
Frequently asked questions
What is the current stock price of CVS Health (CVS)?
CVS Health last traded at 88.84. The quote on this page refreshes every few seconds while US markets are open.
What is CVS Health's market cap?
About 113.62B.
What is the P/E ratio of CVS Health?
The trailing twelve-month P/E is 23.44, below its own 5-year average of 32.17 — toward the top of its historical range (68.87% percentile). See the Valuation tab for the full history.
Does CVS Health pay a dividend?
Yes. The trailing dividend yield is 2.99%. See the Dividends tab for the full payment history.
Is CVS Health a buy according to analysts?
The consensus of 18 analysts is a Buy rating, with an average 12-month price target of 115.00, which implies 29.4% upside from the current price. This is not investment advice.
Quote time 2026-09-18 20:02:32 · For reference only, not investment advice.